Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Reproduction ; 149(1): 1-10, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25433026

RESUMO

In this study, we investigated the interaction between the Notch pathway and progesterone to maintain the functionality of the corpus luteum (CL). When Notch signaling is activated, the γ-secretase complex releases the active intracellular domains (NICD) of their receptors, which exert survival effects. We designed studies to analyze whether the in vitro inhibition of Notch affects progesterone production, steroidogenic regulators, apoptotic parameters, and signaling transduction pathways in the cultures of CL isolated from pregnant and superovulated rats. We detected a decrease in progesterone production when corpora lutea (CL) were incubated with N-(N-(3,5-difluorophenacetyl-l-alanyl))-S-phenylglycine t-butyl ester (DAPT), a γ-secretase inhibitor. This effect could be in part due to the decrease detected in the CL protein levels of P450scc because STAR and 3ß-hydroxysteroid dehydrogenase were not affected by Notch inhibition. Besides, the addition of aminoglutethimide to the CL culture medium decreased NICD of NOTCH1. We observed an increase in the expression of active CASPASE3 (CASP3) after inhibition by Notch, which was reversed by the presence of progesterone. The BAX:BCLXL ratio was increased in CL treated with DAPT and the presence of progesterone reversed this effect. In addition, phosphorylation of AKT was inhibited in CL treated with DAPT, but had no effect on ERK activation. To demonstrate that the action of DAPT is specifically related with the inhibition of Notch, CLs were incubated with DLL4 antibody and a decrease in progesterone production was detected. These results suggest the existence of a novel link between progesterone and the Notch signaling pathway to maintain the functionality of the CL.


Assuntos
Corpo Lúteo/efeitos dos fármacos , Corpo Lúteo/metabolismo , Ovulação/efeitos dos fármacos , Ovulação/metabolismo , Progesterona/farmacologia , Receptores Notch/metabolismo , Transdução de Sinais/efeitos dos fármacos , Animais , Apoptose/efeitos dos fármacos , Western Blotting , Caspase 3/metabolismo , Células Cultivadas , Corpo Lúteo/citologia , Feminino , Técnicas Imunoenzimáticas , Fosforilação/efeitos dos fármacos , Gravidez , Radioimunoensaio , Ratos , Ratos Sprague-Dawley
2.
Am J Otolaryngol ; 3(4): 229-34, 1982.
Artigo em Inglês | MEDLINE | ID: mdl-7149137

RESUMO

The sleep apnea syndrome is characterized by very loud snoring associated with apneic episodes during sleep. Electromyographic studies have shown loss of tone of the tongue and pharyngeal muscles during the apneic episodes. Fiberoptic endoscopic studies have pinpointed the site of the obstruction at the oropharynx. Until now, the only proven effective treatment has been tracheostomy. Ten patients with obstructive sleep apnea syndrome have been effectively treated by palatopharyngoplasty. The technique is described. It is simple, and results are immediate and dramatic.


Assuntos
Palato Mole/cirurgia , Faringe/cirurgia , Síndromes da Apneia do Sono/cirurgia , Adulto , Feminino , Humanos , Masculino , Métodos , Pessoa de Meia-Idade , Síndromes da Apneia do Sono/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA